Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61777089 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.61777089 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.24473485 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24473485 |
5 | * aromatic amino acid family catabolic process (GO:0009074) | 7.11367166 |
6 | * indole-containing compound catabolic process (GO:0042436) | 6.59279843 |
7 | * indolalkylamine catabolic process (GO:0046218) | 6.59279843 |
8 | * tryptophan catabolic process (GO:0006569) | 6.59279843 |
9 | * kynurenine metabolic process (GO:0070189) | 6.31675687 |
10 | * tryptophan metabolic process (GO:0006568) | 6.13690034 |
11 | bile acid biosynthetic process (GO:0006699) | 6.11963541 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.10021578 |
13 | glyoxylate metabolic process (GO:0046487) | 5.93515457 |
14 | urea cycle (GO:0000050) | 5.70359394 |
15 | urea metabolic process (GO:0019627) | 5.70359394 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62811430 |
17 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.53162603 |
18 | complement activation, alternative pathway (GO:0006957) | 5.48160426 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.45560560 |
20 | cysteine metabolic process (GO:0006534) | 5.39801418 |
21 | regulation of protein activation cascade (GO:2000257) | 5.39325844 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.36120163 |
23 | regulation of fibrinolysis (GO:0051917) | 5.28663953 |
24 | protein carboxylation (GO:0018214) | 5.28071591 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.28071591 |
26 | sulfur amino acid catabolic process (GO:0000098) | 5.27908633 |
27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.25279827 |
28 | nitrogen cycle metabolic process (GO:0071941) | 5.24365708 |
29 | serine family amino acid catabolic process (GO:0009071) | 5.15469049 |
30 | bile acid metabolic process (GO:0008206) | 5.14884413 |
31 | positive regulation of heat generation (GO:0031652) | 5.11490454 |
32 | * aromatic amino acid family metabolic process (GO:0009072) | 5.05914621 |
33 | regulation of complement activation (GO:0030449) | 5.04778606 |
34 | negative regulation of interleukin-12 production (GO:0032695) | 4.96656506 |
35 | homocysteine metabolic process (GO:0050667) | 4.92937851 |
36 | regulation of fever generation (GO:0031620) | 4.82537830 |
37 | tyrosine metabolic process (GO:0006570) | 4.80411097 |
38 | lysine metabolic process (GO:0006553) | 4.79590231 |
39 | lysine catabolic process (GO:0006554) | 4.79590231 |
40 | regulation of triglyceride catabolic process (GO:0010896) | 4.75347275 |
41 | * alpha-amino acid catabolic process (GO:1901606) | 4.70671933 |
42 | amino-acid betaine metabolic process (GO:0006577) | 4.68007989 |
43 | reverse cholesterol transport (GO:0043691) | 4.66657566 |
44 | regulation of cholesterol esterification (GO:0010872) | 4.65414101 |
45 | response to peptidoglycan (GO:0032494) | 4.64127004 |
46 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.61519242 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61373328 |
48 | protein-lipid complex remodeling (GO:0034368) | 4.61373328 |
49 | macromolecular complex remodeling (GO:0034367) | 4.61373328 |
50 | triglyceride homeostasis (GO:0070328) | 4.53428255 |
51 | acylglycerol homeostasis (GO:0055090) | 4.53428255 |
52 | * indolalkylamine metabolic process (GO:0006586) | 4.52287057 |
53 | negative regulation of sterol transport (GO:0032372) | 4.51378680 |
54 | negative regulation of cholesterol transport (GO:0032375) | 4.51378680 |
55 | coenzyme catabolic process (GO:0009109) | 4.47416302 |
56 | cellular ketone body metabolic process (GO:0046950) | 4.46313989 |
57 | * amine catabolic process (GO:0009310) | 4.46204815 |
58 | * cellular biogenic amine catabolic process (GO:0042402) | 4.46204815 |
59 | phospholipid efflux (GO:0033700) | 4.43677098 |
60 | bile acid and bile salt transport (GO:0015721) | 4.42469165 |
61 | glycine metabolic process (GO:0006544) | 4.40256941 |
62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.35965032 |
63 | regulation of chronic inflammatory response (GO:0002676) | 4.34782837 |
64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.34689353 |
65 | regulation of vitamin metabolic process (GO:0030656) | 4.33519000 |
66 | cellular glucuronidation (GO:0052695) | 4.32205090 |
67 | * cellular amino acid catabolic process (GO:0009063) | 4.32045135 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.29903161 |
69 | glutamate metabolic process (GO:0006536) | 4.24949125 |
70 | serine family amino acid metabolic process (GO:0009069) | 4.24839467 |
71 | ethanol oxidation (GO:0006069) | 4.21024196 |
72 | plasma lipoprotein particle clearance (GO:0034381) | 4.19943308 |
73 | * benzene-containing compound metabolic process (GO:0042537) | 4.18485685 |
74 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.15985770 |
75 | regulation of chemokine biosynthetic process (GO:0045073) | 4.14695827 |
76 | cellular modified amino acid catabolic process (GO:0042219) | 4.13769317 |
77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.12875300 |
78 | regulation of mononuclear cell migration (GO:0071675) | 4.10820992 |
79 | cholesterol efflux (GO:0033344) | 4.07946650 |
80 | regulation of interferon-alpha production (GO:0032647) | 4.04670340 |
81 | serine family amino acid biosynthetic process (GO:0009070) | 4.03773981 |
82 | aldehyde catabolic process (GO:0046185) | 4.00790467 |
83 | drug catabolic process (GO:0042737) | 3.96682319 |
84 | arginine metabolic process (GO:0006525) | 3.96438797 |
85 | regulation of heat generation (GO:0031650) | 3.95615630 |
86 | complement activation, classical pathway (GO:0006958) | 3.94862606 |
87 | fibrinolysis (GO:0042730) | 3.93088164 |
88 | regulation of podosome assembly (GO:0071801) | 3.92174930 |
89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90872691 |
90 | macrophage activation involved in immune response (GO:0002281) | 3.89308232 |
91 | complement activation (GO:0006956) | 3.87142639 |
92 | * dicarboxylic acid biosynthetic process (GO:0043650) | 3.86586016 |
93 | uronic acid metabolic process (GO:0006063) | 3.85807967 |
94 | glucuronate metabolic process (GO:0019585) | 3.85807967 |
95 | ketone body metabolic process (GO:1902224) | 3.85456170 |
96 | plasma lipoprotein particle assembly (GO:0034377) | 3.84291959 |
97 | acetyl-CoA metabolic process (GO:0006084) | 3.82005175 |
98 | cofactor catabolic process (GO:0051187) | 3.80050696 |
99 | protein activation cascade (GO:0072376) | 3.79734648 |
100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79359098 |
101 | cytolysis (GO:0019835) | 3.78717228 |
102 | phospholipid homeostasis (GO:0055091) | 3.78594272 |
103 | * organic acid catabolic process (GO:0016054) | 3.78483036 |
104 | * carboxylic acid catabolic process (GO:0046395) | 3.78483036 |
105 | short-chain fatty acid metabolic process (GO:0046459) | 3.78249464 |
106 | neutrophil activation involved in immune response (GO:0002283) | 3.74384012 |
107 | urate metabolic process (GO:0046415) | 3.72588552 |
108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72564525 |
109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72564525 |
110 | cellular response to type I interferon (GO:0071357) | 3.71942427 |
111 | type I interferon signaling pathway (GO:0060337) | 3.71942427 |
112 | immunoglobulin mediated immune response (GO:0016064) | 3.71108337 |
113 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.70570654 |
114 | response to type I interferon (GO:0034340) | 3.67354195 |
115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66660357 |
116 | negative regulation of lipase activity (GO:0060192) | 3.66582006 |
117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66577101 |
118 | cholesterol homeostasis (GO:0042632) | 3.66537631 |
119 | drug transmembrane transport (GO:0006855) | 3.64748063 |
120 | positive regulation of lipid catabolic process (GO:0050996) | 3.62983552 |
121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.62827557 |
122 | sterol homeostasis (GO:0055092) | 3.60534245 |
123 | T-helper 1 type immune response (GO:0042088) | 3.55140588 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 3.54954667 |
125 | exogenous drug catabolic process (GO:0042738) | 3.54411828 |
126 | * NAD biosynthetic process (GO:0009435) | 3.54127971 |
127 | response to protozoan (GO:0001562) | 3.48984592 |
128 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.47896454 |
129 | glycosphingolipid catabolic process (GO:0046479) | 3.47778622 |
130 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.46312195 |
131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43186589 |
132 | defense response to protozoan (GO:0042832) | 3.40415189 |
133 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.39648227 |
134 | monocyte chemotaxis (GO:0002548) | 3.38301677 |
135 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.37968811 |
136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36022450 |
137 | oligosaccharide catabolic process (GO:0009313) | 3.32986350 |
138 | positive regulation of interferon-alpha production (GO:0032727) | 3.31408426 |
139 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.30132269 |
140 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.29082244 |
141 | regulation of immunoglobulin secretion (GO:0051023) | 3.28622179 |
142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.28081658 |
143 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.26166085 |
144 | myeloid dendritic cell differentiation (GO:0043011) | 3.24340321 |
145 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.24309022 |
146 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.21617932 |
147 | positive regulation of acute inflammatory response (GO:0002675) | 3.21284828 |
148 | germinal center formation (GO:0002467) | 3.13711050 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.13116267 |
150 | cellular response to lipopolysaccharide (GO:0071222) | 3.11278967 |
151 | negative regulation of growth of symbiont in host (GO:0044130) | 3.10770523 |
152 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.10770523 |
153 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.10770523 |
154 | regulation of growth of symbiont in host (GO:0044126) | 3.10770523 |
155 | positive regulation of type 2 immune response (GO:0002830) | 3.10470674 |
156 | glycolipid catabolic process (GO:0019377) | 3.09002421 |
157 | granulocyte activation (GO:0036230) | 3.08460350 |
158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08248027 |
159 | NIK/NF-kappaB signaling (GO:0038061) | 3.06049601 |
160 | ceramide catabolic process (GO:0046514) | 3.05723564 |
161 | cellular response to molecule of bacterial origin (GO:0071219) | 3.03076944 |
162 | negative regulation of lipid storage (GO:0010888) | 3.02175011 |
163 | detection of molecule of bacterial origin (GO:0032490) | 3.02072630 |
164 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01153176 |
165 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.00495044 |
166 | positive regulation of interleukin-6 production (GO:0032755) | 3.00332310 |
167 | regulation of interleukin-12 production (GO:0032655) | 3.00234971 |
168 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.98322638 |
169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.96040663 |
170 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.94554622 |
171 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.91996686 |
172 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.91703189 |
173 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.90412177 |
174 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.89154239 |
175 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.87061434 |
176 | positive regulation of interferon-beta production (GO:0032728) | 2.87052883 |
177 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85865070 |
178 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.85139689 |
179 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82441263 |
180 | modulation by symbiont of host defense response (GO:0052031) | 2.82441263 |
181 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82441263 |
182 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82441263 |
183 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82441263 |
184 | modulation by symbiont of host immune response (GO:0052553) | 2.82441263 |
185 | myeloid dendritic cell activation (GO:0001773) | 2.81870875 |
186 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80660963 |
187 | cellular response to nicotine (GO:0071316) | 2.80539841 |
188 | cellular response to interferon-gamma (GO:0071346) | 2.79940415 |
189 | regulation of T-helper cell differentiation (GO:0045622) | 2.79905194 |
190 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.76493477 |
191 | negative regulation of amino acid transport (GO:0051956) | 2.74986983 |
192 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.74781316 |
193 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.74355858 |
194 | regulation of antigen processing and presentation (GO:0002577) | 2.73492945 |
195 | response to interferon-gamma (GO:0034341) | 2.68075998 |
196 | eosinophil chemotaxis (GO:0048245) | 2.67719949 |
197 | response to muramyl dipeptide (GO:0032495) | 2.66536151 |
198 | B cell mediated immunity (GO:0019724) | 2.66292414 |
199 | cellular response to ethanol (GO:0071361) | 2.66114352 |
200 | myeloid cell activation involved in immune response (GO:0002275) | 2.65766798 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.32759401 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.21386463 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14371226 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44715327 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21315254 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09816313 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.40188149 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.18102408 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.09351628 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04701768 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00614700 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56871626 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56440476 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55742330 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51889502 |
16 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.37772569 |
17 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22406738 |
18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08278023 |
19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05408457 |
20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03637581 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01734265 |
22 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8159699 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.92216727 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87681530 |
25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87222564 |
26 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86801017 |
27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82311601 |
28 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70422735 |
29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68549750 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67891640 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67373933 |
32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.64831786 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64599750 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63521971 |
35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58211541 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48179346 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47661526 |
38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44121985 |
39 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42367485 |
40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40847681 |
41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37831911 |
42 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37503933 |
43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35712188 |
44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.32803982 |
45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32449123 |
46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32366156 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30405434 |
48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.29503260 |
49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28604360 |
50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28508031 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27819960 |
52 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22842281 |
53 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21469909 |
54 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18638044 |
55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17564293 |
56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14510788 |
57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12920515 |
58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12739366 |
59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12252486 |
60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06141490 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05797740 |
62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04105146 |
63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02330771 |
64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95831627 |
65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93965892 |
66 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92635672 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91682132 |
68 | MYB_26560356_Chip-Seq_TH1_Human | 0.91668238 |
69 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91082515 |
70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90517771 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90443173 |
72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90102641 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89461804 |
74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88750088 |
75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88581575 |
76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88425218 |
77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87998617 |
78 | MAF_26560356_Chip-Seq_TH1_Human | 0.87366269 |
79 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86277846 |
80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86002469 |
81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85065835 |
82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82036075 |
83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82003466 |
84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80792968 |
85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80549241 |
86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79495443 |
87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78486963 |
88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76687184 |
89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76185858 |
90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.75254661 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74929605 |
92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73934563 |
93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72532987 |
94 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72074919 |
95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71466620 |
96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71062158 |
97 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70896614 |
98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70353193 |
99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69176313 |
100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68344711 |
101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67361637 |
102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67266334 |
103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.65485917 |
104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64670089 |
105 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64200270 |
106 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.63967866 |
107 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.63571588 |
108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63445946 |
109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.62641530 |
110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61739998 |
111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61739998 |
112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61413802 |
113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60690992 |
114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60428102 |
115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.58842480 |
116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.58828450 |
117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.57448754 |
118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56858391 |
119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54405389 |
120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54307847 |
121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54003301 |
122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53484264 |
123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53351401 |
124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.52464332 |
125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52342703 |
126 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.51953170 |
127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.51782903 |
128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51612891 |
129 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51474377 |
130 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51062672 |
131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50647961 |
132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50629267 |
133 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49937820 |
134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49413713 |
135 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.49381057 |
136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.48597956 |
137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47628830 |
138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47067865 |
139 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46929013 |
140 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.46306005 |
141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46244417 |
142 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46155058 |
143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46063235 |
144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45322219 |
145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45121730 |
146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44493941 |
147 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.44275302 |
148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43897867 |
149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.42972230 |
150 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.42804380 |
151 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.42667859 |
152 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42514800 |
153 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42199452 |
154 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42023253 |
155 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.41610351 |
156 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.41245324 |
157 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.41117482 |
158 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.39454537 |
159 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.39402576 |
160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39048448 |
161 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38494766 |
162 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.37764894 |
163 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37033203 |
164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36506300 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.21229131 |
2 | MP0005360_urolithiasis | 7.57490649 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.33844174 |
4 | MP0005365_abnormal_bile_salt | 6.09901175 |
5 | MP0003303_peritoneal_inflammation | 5.41687680 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.01236207 |
7 | MP0003806_abnormal_nucleotide_metabolis | 4.16193872 |
8 | MP0003252_abnormal_bile_duct | 3.95489402 |
9 | MP0010329_abnormal_lipoprotein_level | 3.46110875 |
10 | MP0002148_abnormal_hypersensitivity_rea | 3.42104278 |
11 | MP0009840_abnormal_foam_cell | 2.99414806 |
12 | MP0005083_abnormal_biliary_tract | 2.84514215 |
13 | MP0005332_abnormal_amino_acid | 2.82605666 |
14 | MP0003195_calcinosis | 2.80136392 |
15 | MP0004510_myositis | 2.74838576 |
16 | MP0005000_abnormal_immune_tolerance | 2.59123649 |
17 | MP0005671_abnormal_response_to | 2.58119708 |
18 | MP0001666_abnormal_nutrient_absorption | 2.57281556 |
19 | MP0004019_abnormal_vitamin_homeostasis | 2.33326670 |
20 | MP0002138_abnormal_hepatobiliary_system | 2.24504404 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.19513611 |
22 | MP0000609_abnormal_liver_physiology | 2.13853391 |
23 | MP0005167_abnormal_blood-brain_barrier | 2.11463106 |
24 | MP0002452_abnormal_antigen_presenting | 2.07957392 |
25 | MP0003300_gastrointestinal_ulcer | 2.03943002 |
26 | MP0002723_abnormal_immune_serum | 2.03890088 |
27 | MP0002118_abnormal_lipid_homeostasis | 2.03784269 |
28 | MP0001533_abnormal_skeleton_physiology | 1.94684183 |
29 | MP0003868_abnormal_feces_composition | 1.89950972 |
30 | MP0000343_altered_response_to | 1.89863443 |
31 | MP0003172_abnormal_lysosome_physiology | 1.89739967 |
32 | MP0006054_spinal_hemorrhage | 1.85481903 |
33 | MP0008004_abnormal_stomach_pH | 1.83981565 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.80882171 |
35 | MP0009278_abnormal_bone_marrow | 1.76445352 |
36 | MP0001764_abnormal_homeostasis | 1.69385847 |
37 | MP0010155_abnormal_intestine_physiology | 1.68558372 |
38 | MP0009697_abnormal_copulation | 1.68417175 |
39 | MP0002332_abnormal_exercise_endurance | 1.67307927 |
40 | MP0001545_abnormal_hematopoietic_system | 1.66068543 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.66068543 |
42 | MP0003011_delayed_dark_adaptation | 1.66043819 |
43 | MP0004947_skin_inflammation | 1.65213966 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60517265 |
45 | MP0001819_abnormal_immune_cell | 1.59981773 |
46 | MP0002420_abnormal_adaptive_immunity | 1.59398123 |
47 | MP0000685_abnormal_immune_system | 1.57339139 |
48 | MP0005451_abnormal_body_composition | 1.56578517 |
49 | MP0005310_abnormal_salivary_gland | 1.55211688 |
50 | MP0002405_respiratory_system_inflammati | 1.40562884 |
51 | MP0009643_abnormal_urine_homeostasis | 1.35879406 |
52 | MP0003448_altered_tumor_morphology | 1.33200044 |
53 | MP0002998_abnormal_bone_remodeling | 1.31730421 |
54 | MP0003453_abnormal_keratinocyte_physiol | 1.30856251 |
55 | MP0003186_abnormal_redox_activity | 1.28444961 |
56 | MP0009764_decreased_sensitivity_to | 1.18995856 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.17926325 |
58 | MP0000598_abnormal_liver_morphology | 1.17798705 |
59 | MP0001501_abnormal_sleep_pattern | 1.13628001 |
60 | MP0000716_abnormal_immune_system | 1.12769007 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.11469950 |
62 | MP0005647_abnormal_sex_gland | 1.10833802 |
63 | MP0000858_altered_metastatic_potential | 1.08509475 |
64 | MP0008469_abnormal_protein_level | 1.03631110 |
65 | MP0005164_abnormal_response_to | 1.03454859 |
66 | MP0009763_increased_sensitivity_to | 1.02474934 |
67 | MP0002876_abnormal_thyroid_physiology | 1.01641088 |
68 | MP0005636_abnormal_mineral_homeostasis | 0.98916937 |
69 | MP0005408_hypopigmentation | 0.97935994 |
70 | MP0000604_amyloidosis | 0.97075187 |
71 | MP0005084_abnormal_gallbladder_morpholo | 0.96959378 |
72 | MP0002254_reproductive_system_inflammat | 0.93208516 |
73 | MP0003646_muscle_fatigue | 0.91352390 |
74 | MP0009642_abnormal_blood_homeostasis | 0.90531959 |
75 | MP0002398_abnormal_bone_marrow | 0.86699462 |
76 | MP0005670_abnormal_white_adipose | 0.86309557 |
77 | MP0003705_abnormal_hypodermis_morpholog | 0.85449671 |
78 | MP0000689_abnormal_spleen_morphology | 0.84649122 |
79 | MP0001663_abnormal_digestive_system | 0.84416209 |
80 | MP0000920_abnormal_myelination | 0.82843396 |
81 | MP0003183_abnormal_peptide_metabolism | 0.81591049 |
82 | MP0006036_abnormal_mitochondrial_physio | 0.80932441 |
83 | MP0005376_homeostasis/metabolism_phenot | 0.80149224 |
84 | MP0002429_abnormal_blood_cell | 0.79756945 |
85 | MP0009765_abnormal_xenobiotic_induced | 0.79609995 |
86 | MP0010368_abnormal_lymphatic_system | 0.76431861 |
87 | MP0005220_abnormal_exocrine_pancreas | 0.74378940 |
88 | MP0005165_increased_susceptibility_to | 0.74251010 |
89 | MP0002078_abnormal_glucose_homeostasis | 0.74245740 |
90 | MP0005390_skeleton_phenotype | 0.74113895 |
91 | MP0005535_abnormal_body_temperature | 0.69476058 |
92 | MP0002277_abnormal_respiratory_mucosa | 0.69415028 |
93 | MP0001542_abnormal_bone_strength | 0.68434216 |
94 | MP0005464_abnormal_platelet_physiology | 0.68132133 |
95 | MP0003436_decreased_susceptibility_to | 0.67563212 |
96 | MP0002722_abnormal_immune_system | 0.67201972 |
97 | MP0005334_abnormal_fat_pad | 0.66428004 |
98 | MP0002837_dystrophic_cardiac_calcinosis | 0.66319156 |
99 | MP0001756_abnormal_urination | 0.65240601 |
100 | MP0001661_extended_life_span | 0.64589000 |
101 | MP0003690_abnormal_glial_cell | 0.63692101 |
102 | MP0001835_abnormal_antigen_presentation | 0.63572192 |
103 | MP0002928_abnormal_bile_duct | 0.63322080 |
104 | MP0002971_abnormal_brown_adipose | 0.63036809 |
105 | MP0005266_abnormal_metabolism | 0.62692362 |
106 | MP0000371_diluted_coat_color | 0.62113771 |
107 | MP0002136_abnormal_kidney_physiology | 0.60903391 |
108 | MP0004381_abnormal_hair_follicle | 0.59014305 |
109 | MP0003763_abnormal_thymus_physiology | 0.58085822 |
110 | MP0004130_abnormal_muscle_cell | 0.57749523 |
111 | MP0003724_increased_susceptibility_to | 0.55113015 |
112 | MP0001853_heart_inflammation | 0.54959949 |
113 | MP0010307_abnormal_tumor_latency | 0.54629902 |
114 | MP0003633_abnormal_nervous_system | 0.53913406 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.52656815 |
116 | MP0002693_abnormal_pancreas_physiology | 0.51509729 |
117 | MP0000639_abnormal_adrenal_gland | 0.50648030 |
118 | MP0006035_abnormal_mitochondrial_morpho | 0.50305302 |
119 | MP0003795_abnormal_bone_structure | 0.50275793 |
120 | MP0009053_abnormal_anal_canal | 0.49232023 |
121 | MP0001845_abnormal_inflammatory_respons | 0.48834182 |
122 | MP0003638_abnormal_response/metabolism_ | 0.48545105 |
123 | MP0005448_abnormal_energy_balance | 0.46696299 |
124 | MP0005395_other_phenotype | 0.46492098 |
125 | MP0003329_amyloid_beta_deposits | 0.46347527 |
126 | MP0004782_abnormal_surfactant_physiolog | 0.45700200 |
127 | MP0008873_increased_physiological_sensi | 0.43390376 |
128 | MP0005166_decreased_susceptibility_to | 0.42854029 |
129 | MP0008874_decreased_physiological_sensi | 0.42675724 |
130 | MP0006082_CNS_inflammation | 0.41051488 |
131 | MP0005075_abnormal_melanosome_morpholog | 0.40670175 |
132 | MP0003953_abnormal_hormone_level | 0.36949719 |
133 | MP0009785_altered_susceptibility_to | 0.36885012 |
134 | MP0002419_abnormal_innate_immunity | 0.36593752 |
135 | MP0003718_maternal_effect | 0.36186815 |
136 | MP0001790_abnormal_immune_system | 0.36169177 |
137 | MP0005387_immune_system_phenotype | 0.36169177 |
138 | MP0005025_abnormal_response_to | 0.35516801 |
139 | MP0005058_abnormal_lysosome_morphology | 0.35281301 |
140 | MP0002168_other_aberrant_phenotype | 0.34851677 |
141 | MP0000249_abnormal_blood_vessel | 0.34410657 |
142 | MP0003075_altered_response_to | 0.34306483 |
143 | MP0009672_abnormal_birth_weight | 0.34095009 |
144 | MP0004883_abnormal_blood_vessel | 0.33303119 |
145 | MP0000230_abnormal_systemic_arterial | 0.32593604 |
146 | MP0002822_catalepsy | 0.32589657 |
147 | MP0000427_abnormal_hair_cycle | 0.32052576 |
148 | MP0005666_abnormal_adipose_tissue | 0.31712316 |
149 | MP0000579_abnormal_nail_morphology | 0.31589600 |
150 | MP0001881_abnormal_mammary_gland | 0.30743307 |
151 | MP0002132_abnormal_respiratory_system | 0.30716647 |
152 | MP0001800_abnormal_humoral_immune | 0.30546647 |
153 | MP0009115_abnormal_fat_cell | 0.29927613 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.18325473 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16354869 |
3 | Deep venous thrombosis (HP:0002625) | 7.11122930 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 6.92407129 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.92407129 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.92407129 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51424093 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 6.45174321 |
9 | Hypobetalipoproteinemia (HP:0003563) | 6.23560106 |
10 | Xanthomatosis (HP:0000991) | 6.06181575 |
11 | Complement deficiency (HP:0004431) | 5.40272625 |
12 | Hyperlipoproteinemia (HP:0010980) | 5.25860164 |
13 | Vacuolated lymphocytes (HP:0001922) | 5.06592900 |
14 | Joint hemorrhage (HP:0005261) | 4.85538158 |
15 | Optic neuritis (HP:0100653) | 4.76331444 |
16 | Retrobulbar optic neuritis (HP:0100654) | 4.76331444 |
17 | Increased cerebral lipofuscin (HP:0011813) | 4.66625118 |
18 | Abnormality of macrophages (HP:0004311) | 4.59661906 |
19 | Hypolipoproteinemia (HP:0010981) | 4.56206031 |
20 | Orchitis (HP:0100796) | 4.56187652 |
21 | Hyperammonemia (HP:0001987) | 4.54568762 |
22 | Epidermoid cyst (HP:0200040) | 4.52348943 |
23 | Disinhibition (HP:0000734) | 4.51242075 |
24 | Stomatitis (HP:0010280) | 4.46731786 |
25 | Hyperglycinemia (HP:0002154) | 4.39401272 |
26 | Recurrent bacterial skin infections (HP:0005406) | 4.37621373 |
27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35064511 |
28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.29207691 |
29 | Ketosis (HP:0001946) | 4.28305316 |
30 | Dysostosis multiplex (HP:0000943) | 4.27089743 |
31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24060613 |
32 | Abnormality of methionine metabolism (HP:0010901) | 4.24040950 |
33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21917300 |
34 | Loss of speech (HP:0002371) | 4.17588658 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17391435 |
36 | Fat malabsorption (HP:0002630) | 4.13494164 |
37 | Hyperglycinuria (HP:0003108) | 4.06557570 |
38 | Recurrent abscess formation (HP:0002722) | 4.01562074 |
39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.99897224 |
40 | Abnormality of glycine metabolism (HP:0010895) | 3.99772583 |
41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99772583 |
42 | Abnormality of complement system (HP:0005339) | 3.98148614 |
43 | Myositis (HP:0100614) | 3.98118687 |
44 | Hypoalphalipoproteinemia (HP:0003233) | 3.88992761 |
45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86575195 |
46 | Autoimmune thrombocytopenia (HP:0001973) | 3.82568779 |
47 | Mutism (HP:0002300) | 3.75766882 |
48 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69165713 |
49 | Hypoglycemic coma (HP:0001325) | 3.66767697 |
50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60815172 |
51 | Mediastinal lymphadenopathy (HP:0100721) | 3.45517931 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 3.44164607 |
53 | Eczematoid dermatitis (HP:0000976) | 3.43536427 |
54 | Hypercholesterolemia (HP:0003124) | 3.43010923 |
55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.38257173 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.38257173 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.38257173 |
58 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35089308 |
59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25948525 |
60 | Hyperbilirubinemia (HP:0002904) | 3.25303613 |
61 | Keratoconjunctivitis sicca (HP:0001097) | 3.23856265 |
62 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.18656366 |
63 | Mucopolysacchariduria (HP:0008155) | 3.18656366 |
64 | Steatorrhea (HP:0002570) | 3.17471193 |
65 | Abnormality of purine metabolism (HP:0004352) | 3.16298299 |
66 | Delayed CNS myelination (HP:0002188) | 3.15830702 |
67 | Ketoacidosis (HP:0001993) | 3.07505536 |
68 | Keratoconjunctivitis (HP:0001096) | 3.05450768 |
69 | Abnormality of serum amino acid levels (HP:0003112) | 3.03913224 |
70 | Myocardial infarction (HP:0001658) | 3.03260117 |
71 | Nuclear cataract (HP:0100018) | 3.00881948 |
72 | Increased serum ferritin (HP:0003281) | 2.95820176 |
73 | Hypochromic microcytic anemia (HP:0004840) | 2.95532586 |
74 | Hepatocellular carcinoma (HP:0001402) | 2.91902810 |
75 | Systemic lupus erythematosus (HP:0002725) | 2.89497664 |
76 | Spontaneous abortion (HP:0005268) | 2.89116129 |
77 | Gangrene (HP:0100758) | 2.87286494 |
78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.86401844 |
79 | Neurofibrillary tangles (HP:0002185) | 2.84248991 |
80 | Hematochezia (HP:0002573) | 2.78775215 |
81 | Pulmonary infiltrates (HP:0002113) | 2.74432894 |
82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.72186293 |
83 | Metabolic acidosis (HP:0001942) | 2.72133048 |
84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71630750 |
85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69995963 |
86 | Vasculitis (HP:0002633) | 2.69956528 |
87 | Apathy (HP:0000741) | 2.69615921 |
88 | Inappropriate behavior (HP:0000719) | 2.68382767 |
89 | Gout (HP:0001997) | 2.64970648 |
90 | Nausea (HP:0002018) | 2.64304623 |
91 | Skin nodule (HP:0200036) | 2.62831671 |
92 | Vascular calcification (HP:0004934) | 2.61184875 |
93 | Diminished motivation (HP:0000745) | 2.59704802 |
94 | Lethargy (HP:0001254) | 2.59406118 |
95 | Mitral stenosis (HP:0001718) | 2.57983852 |
96 | Purpura (HP:0000979) | 2.57747507 |
97 | Axonal loss (HP:0003447) | 2.56745668 |
98 | Spastic diplegia (HP:0001264) | 2.55993629 |
99 | Parakeratosis (HP:0001036) | 2.55640937 |
100 | Dicarboxylic aciduria (HP:0003215) | 2.54726656 |
101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54726656 |
102 | Alkalosis (HP:0001948) | 2.50686358 |
103 | Hemoptysis (HP:0002105) | 2.48428143 |
104 | Acanthocytosis (HP:0001927) | 2.48399893 |
105 | Hypoglycemic seizures (HP:0002173) | 2.43333013 |
106 | Obstructive lung disease (HP:0006536) | 2.43076536 |
107 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43076536 |
108 | Polyneuropathy (HP:0001271) | 2.42262728 |
109 | Agnosia (HP:0010524) | 2.42168767 |
110 | Hyperuricemia (HP:0002149) | 2.41523099 |
111 | Increased purine levels (HP:0004368) | 2.41523099 |
112 | Upper motor neuron abnormality (HP:0002127) | 2.41211257 |
113 | Glomerulonephritis (HP:0000099) | 2.40672767 |
114 | Cerebral edema (HP:0002181) | 2.38705048 |
115 | Progressive neurologic deterioration (HP:0002344) | 2.37915397 |
116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37856591 |
117 | Gingival bleeding (HP:0000225) | 2.33107616 |
118 | Recurrent skin infections (HP:0001581) | 2.32905390 |
119 | Neonatal onset (HP:0003623) | 2.32772329 |
120 | Irritability (HP:0000737) | 2.30956531 |
121 | Metaphyseal irregularity (HP:0003025) | 2.30649259 |
122 | Cardiovascular calcification (HP:0011915) | 2.28999759 |
123 | Amyloidosis (HP:0011034) | 2.27219836 |
124 | Abnormal gallbladder morphology (HP:0012437) | 2.26633964 |
125 | Basal ganglia calcification (HP:0002135) | 2.26583761 |
126 | Petechiae (HP:0000967) | 2.25066123 |
127 | Increased IgM level (HP:0003496) | 2.24950454 |
128 | Pulmonary embolism (HP:0002204) | 2.19990187 |
129 | Cholelithiasis (HP:0001081) | 2.19326419 |
130 | Pancreatitis (HP:0001733) | 2.18958210 |
131 | Arterial thrombosis (HP:0004420) | 2.18610895 |
132 | Meningitis (HP:0001287) | 2.17632004 |
133 | Anorexia (HP:0002039) | 2.16777459 |
134 | Malnutrition (HP:0004395) | 2.16701625 |
135 | Sensorimotor neuropathy (HP:0007141) | 2.15261692 |
136 | Thrombophlebitis (HP:0004418) | 2.14452931 |
137 | Generalized aminoaciduria (HP:0002909) | 2.13481275 |
138 | Enlarged kidneys (HP:0000105) | 2.12638131 |
139 | Vertigo (HP:0002321) | 2.09017751 |
140 | Recurrent fungal infections (HP:0002841) | 2.08592349 |
141 | Recurrent viral infections (HP:0004429) | 2.08432285 |
142 | Hepatosplenomegaly (HP:0001433) | 2.07939470 |
143 | Vomiting (HP:0002013) | 2.07004558 |
144 | Abnormal gallbladder physiology (HP:0012438) | 2.06446208 |
145 | Cholecystitis (HP:0001082) | 2.06446208 |
146 | T lymphocytopenia (HP:0005403) | 2.05874251 |
147 | Menorrhagia (HP:0000132) | 2.04369718 |
148 | Encephalitis (HP:0002383) | 2.03756618 |
149 | Esophageal varix (HP:0002040) | 2.02564098 |
150 | Joint swelling (HP:0001386) | 2.01803286 |
151 | Prolonged neonatal jaundice (HP:0006579) | 2.01280483 |
152 | Abnormality of the pleura (HP:0002103) | 2.00140252 |
153 | Late onset (HP:0003584) | 1.99834924 |
154 | Renal cortical cysts (HP:0000803) | 1.99068068 |
155 | Neuronal loss in central nervous system (HP:0002529) | 1.98756162 |
156 | Rickets (HP:0002748) | 1.98470766 |
157 | Hemorrhage of the eye (HP:0011885) | 1.98460691 |
158 | Memory impairment (HP:0002354) | 1.97794489 |
159 | Opisthotonus (HP:0002179) | 1.97000851 |
160 | Abnormality of T cell number (HP:0011839) | 1.96142313 |
161 | Brushfield spots (HP:0001088) | 1.95415531 |
162 | Autoimmune hemolytic anemia (HP:0001890) | 1.92880395 |
163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91278774 |
164 | Elevated hepatic transaminases (HP:0002910) | 1.90911264 |
165 | Abnormality of proline metabolism (HP:0010907) | 1.90842018 |
166 | Hydroxyprolinuria (HP:0003080) | 1.90842018 |
167 | Poikilocytosis (HP:0004447) | 1.90523136 |
168 | Abnormality of iron homeostasis (HP:0011031) | 1.89244948 |
169 | Cerebral inclusion bodies (HP:0100314) | 1.89167608 |
170 | Proximal tubulopathy (HP:0000114) | 1.89134978 |
171 | Dementia (HP:0000726) | 1.86941758 |
172 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86394845 |
173 | Hypophosphatemic rickets (HP:0004912) | 1.86281760 |
174 | Abnormality of the gallbladder (HP:0005264) | 1.86075159 |
175 | Abnormality of the pericardium (HP:0001697) | 1.86030299 |
176 | Abnormality of B cell number (HP:0010975) | 1.85584202 |
177 | Tetraparesis (HP:0002273) | 1.85182522 |
178 | Recurrent pneumonia (HP:0006532) | 1.82196427 |
179 | Gingivitis (HP:0000230) | 1.81666927 |
180 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80618276 |
181 | Urticaria (HP:0001025) | 1.80134339 |
182 | Interstitial pulmonary disease (HP:0006530) | 1.78055749 |
183 | Abnormality of the periventricular white matter (HP:0002518) | 1.77456866 |
184 | Nephritis (HP:0000123) | 1.73456505 |
185 | Glycosuria (HP:0003076) | 1.72531266 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.89125598 |
2 | TAOK3 | 4.77361633 |
3 | FGFR4 | 4.24562134 |
4 | ERN1 | 4.10721695 |
5 | SIK1 | 3.83205264 |
6 | GRK7 | 3.58514410 |
7 | NME2 | 3.26635652 |
8 | MATK | 2.83793131 |
9 | DDR2 | 2.64991090 |
10 | INSRR | 2.60238405 |
11 | RIPK4 | 2.59845716 |
12 | ERBB4 | 2.53864437 |
13 | BMPR2 | 2.30241927 |
14 | TYK2 | 2.25603782 |
15 | ADRBK2 | 2.17069683 |
16 | MAP3K14 | 2.11208839 |
17 | ACVR1B | 2.06057259 |
18 | MAPK11 | 2.04784893 |
19 | FGR | 2.02277415 |
20 | PIM2 | 2.00983745 |
21 | TAOK1 | 2.00766965 |
22 | TXK | 1.95719063 |
23 | MAP2K4 | 1.92994347 |
24 | TAOK2 | 1.78468831 |
25 | NEK9 | 1.78356679 |
26 | PIK3CG | 1.75824190 |
27 | MST1R | 1.75350104 |
28 | FLT3 | 1.72576931 |
29 | RIPK1 | 1.64013251 |
30 | IRAK3 | 1.60598170 |
31 | JAK3 | 1.45862545 |
32 | MOS | 1.45666823 |
33 | PKN2 | 1.42499137 |
34 | GRK6 | 1.42401530 |
35 | TBK1 | 1.41088424 |
36 | ABL2 | 1.31700969 |
37 | LATS1 | 1.30518347 |
38 | MAP4K1 | 1.28697345 |
39 | MAP2K6 | 1.27481808 |
40 | JAK1 | 1.26433837 |
41 | FRK | 1.17285362 |
42 | JAK2 | 1.16257657 |
43 | MAP2K3 | 1.12353766 |
44 | CSF1R | 1.08287407 |
45 | PRKAA2 | 1.07981356 |
46 | PTK6 | 1.04076731 |
47 | MAP3K7 | 1.03874329 |
48 | KDR | 1.02484889 |
49 | MAPK4 | 1.02281122 |
50 | CSK | 1.02037517 |
51 | DAPK2 | 1.01384110 |
52 | ERBB2 | 1.00757620 |
53 | PRPF4B | 0.98240437 |
54 | MAP3K10 | 0.96289224 |
55 | MAP3K13 | 0.95482359 |
56 | FGFR2 | 0.93768490 |
57 | EPHA3 | 0.93708379 |
58 | PINK1 | 0.93649015 |
59 | STK24 | 0.92973073 |
60 | CAMKK2 | 0.91320608 |
61 | TRIB3 | 0.91246645 |
62 | IKBKE | 0.90869798 |
63 | DYRK3 | 0.87402259 |
64 | MARK3 | 0.86930256 |
65 | EPHB1 | 0.86702703 |
66 | KIT | 0.82914909 |
67 | PRKCZ | 0.81142425 |
68 | STK38L | 0.80477970 |
69 | BLK | 0.80268716 |
70 | MAP3K1 | 0.79846190 |
71 | LCK | 0.78210988 |
72 | MAP3K5 | 0.76284022 |
73 | CDC42BPA | 0.75737411 |
74 | CDK6 | 0.74548282 |
75 | PRKACG | 0.72130732 |
76 | IRAK4 | 0.71682515 |
77 | PRKCQ | 0.71596337 |
78 | SGK3 | 0.70736516 |
79 | PDPK1 | 0.69965402 |
80 | STK10 | 0.69075760 |
81 | MAPK15 | 0.67591092 |
82 | HCK | 0.65463539 |
83 | GRK1 | 0.64430007 |
84 | IRAK1 | 0.63093487 |
85 | DYRK1B | 0.62937054 |
86 | SGK2 | 0.62932804 |
87 | TIE1 | 0.62559597 |
88 | TYRO3 | 0.61810380 |
89 | PIM1 | 0.61670204 |
90 | FGFR3 | 0.60932914 |
91 | MAPK12 | 0.60682049 |
92 | SIK3 | 0.58988229 |
93 | PDK1 | 0.58431369 |
94 | TNK2 | 0.57484562 |
95 | MAPK7 | 0.57129207 |
96 | MAP3K3 | 0.56448211 |
97 | IRAK2 | 0.56336032 |
98 | PRKAA1 | 0.56261103 |
99 | CAMK2G | 0.53492361 |
100 | PKN1 | 0.53157333 |
101 | GSK3A | 0.52060517 |
102 | TEC | 0.51765536 |
103 | PDK2 | 0.49580297 |
104 | CHUK | 0.48930543 |
105 | BTK | 0.48786604 |
106 | CAMK1D | 0.48683327 |
107 | IKBKB | 0.48069992 |
108 | TGFBR2 | 0.46280513 |
109 | FES | 0.45904979 |
110 | MST4 | 0.43461035 |
111 | MAP3K11 | 0.42263435 |
112 | SYK | 0.42193044 |
113 | ZAP70 | 0.41618217 |
114 | SGK223 | 0.41368677 |
115 | SGK494 | 0.41368677 |
116 | MAP3K6 | 0.41056545 |
117 | ITK | 0.40044280 |
118 | LYN | 0.39564105 |
119 | IGF1R | 0.36656253 |
120 | HIPK2 | 0.34021516 |
121 | CSNK1G1 | 0.33401076 |
122 | CDK4 | 0.33026097 |
123 | EGFR | 0.32944883 |
124 | MET | 0.32803459 |
125 | RPS6KA6 | 0.31770389 |
126 | ABL1 | 0.31120963 |
127 | CLK1 | 0.30353429 |
128 | NUAK1 | 0.29851108 |
129 | RPS6KC1 | 0.29124554 |
130 | RPS6KL1 | 0.29124554 |
131 | INSR | 0.27911176 |
132 | MAPK3 | 0.27760890 |
133 | CAMK4 | 0.25790114 |
134 | WNK3 | 0.25521856 |
135 | PTK2 | 0.22550623 |
136 | PRKCA | 0.22081638 |
137 | PRKCG | 0.21893190 |
138 | PRKACB | 0.20976920 |
139 | SIK2 | 0.19155265 |
140 | DAPK3 | 0.18343840 |
141 | BMX | 0.18120918 |
142 | FYN | 0.16888401 |
143 | TGFBR1 | 0.16132967 |
144 | PRKCD | 0.15520873 |
145 | EIF2AK2 | 0.14522147 |
146 | PDGFRB | 0.12899717 |
147 | MAPKAPK2 | 0.10976220 |
148 | EIF2AK3 | 0.10846974 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.64763767 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46276758 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45675090 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40588973 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01282246 |
6 | Asthma_Homo sapiens_hsa05310 | 2.95700439 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.88628474 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.78857680 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.77717174 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76998658 |
11 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72679293 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64487248 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62083229 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.56707072 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56321013 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54981052 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53382104 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52996527 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49278962 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45597744 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45044935 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42763339 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35300879 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29706000 |
25 | Malaria_Homo sapiens_hsa05144 | 2.20726122 |
26 | Peroxisome_Homo sapiens_hsa04146 | 2.18564012 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17467745 |
28 | Legionellosis_Homo sapiens_hsa05134 | 2.15911352 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.12449821 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11992346 |
31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09686280 |
32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98763504 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.98218792 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97000192 |
35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96718736 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91705767 |
37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91597426 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89006513 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84348502 |
40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79883982 |
41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79605395 |
42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77900446 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76903538 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76561140 |
45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74975031 |
46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72599352 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72507982 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.71168611 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70190198 |
50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62649190 |
51 | Influenza A_Homo sapiens_hsa05164 | 1.58636875 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56790205 |
53 | Salmonella infection_Homo sapiens_hsa05132 | 1.55359019 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54577140 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53605782 |
56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48865919 |
57 | Bile secretion_Homo sapiens_hsa04976 | 1.45272468 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44597040 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44484621 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42994122 |
61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41138433 |
62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41077657 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34185278 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33331043 |
65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32317665 |
66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29698649 |
67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29113604 |
68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28101249 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.20597651 |
70 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19773587 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17204576 |
72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15827438 |
73 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15681523 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13699163 |
75 | Phagosome_Homo sapiens_hsa04145 | 1.12985773 |
76 | Measles_Homo sapiens_hsa05162 | 1.12350552 |
77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09657958 |
78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08796156 |
79 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08137322 |
80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05810162 |
81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03472137 |
82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00840369 |
83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98557181 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97051706 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96964383 |
86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95737959 |
87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94478949 |
88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94404246 |
89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94217775 |
90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92859701 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91873078 |
92 | Lysine degradation_Homo sapiens_hsa00310 | 0.85329050 |
93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84516356 |
94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83882296 |
95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83088216 |
96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76227360 |
97 | Hepatitis B_Homo sapiens_hsa05161 | 0.73583802 |
98 | Amoebiasis_Homo sapiens_hsa05146 | 0.71353801 |
99 | Shigellosis_Homo sapiens_hsa05131 | 0.71326252 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69819414 |
101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67461597 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65899258 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63688241 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63298965 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63192552 |
106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57521326 |
107 | Apoptosis_Homo sapiens_hsa04210 | 0.56892075 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56271516 |
109 | Bladder cancer_Homo sapiens_hsa05219 | 0.55516376 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55128242 |
111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55061101 |
112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52913051 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51824029 |
114 | Mineral absorption_Homo sapiens_hsa04978 | 0.48198921 |
115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47892159 |
116 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45128262 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43795397 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42231573 |
119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40787943 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38022818 |
121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36506273 |
122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36085204 |
123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34079144 |
124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33114059 |
125 | Prion diseases_Homo sapiens_hsa05020 | 0.31873123 |
126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29359285 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21744041 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20581777 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.20492387 |
130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19315483 |
131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18354130 |
132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15050878 |
133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14534332 |
134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09922103 |
135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09257467 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08298363 |
137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.07926482 |
138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07283524 |
139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05494769 |
140 | Lysosome_Homo sapiens_hsa04142 | -0.2358861 |
141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2348265 |
142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2171862 |
143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2164206 |
144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2069128 |
145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.2001154 |
146 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1865370 |
147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1686639 |
148 | Pertussis_Homo sapiens_hsa05133 | -0.1627568 |
149 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1594509 |
150 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1545963 |
151 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.1513096 |
152 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1282458 |
153 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1282329 |
154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1223985 |
155 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1216183 |
156 | Hepatitis C_Homo sapiens_hsa05160 | -0.1209082 |
157 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1118849 |
158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1108483 |
159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0716310 |
160 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0568149 |
161 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0501739 |